ViewRay Systems logo

ViewRay Systems(OTC) VRAYQ

Market Cap$200.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2015)-100%
5 Year-100%
1 Year+0%
1 Month+0%
$0.00
+0.00%
+0.00Today
ViewRay Systems last closing stock price
MetricPriceDate
Last closeUSD 0.002026-10-16
ViewRay Systems stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-10-09
1 month+0%USD 0.002026-09-16
3 month+0%USD 0.002026-07-16
Year to date+0%USD 0.002025-12-31
1 year+0%USD 0.002025-10-16
3 year-99.93%USD 0.002023-10-17
5 year-100%USD 6.062021-10-15
Since inception-100%USD 5.002015-08-10

ViewRay Systems Financials at a Glance

Market Cap

$200.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$105.86M

Net Income (TTM)

-$110.42M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-83.16 (Low)

Price

$0.00

Volume

6,496

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Aug 31, 2026

VRAYQ News

CT scan

Why ViewRay Stock Is Sinking Today

Keith SpeightsAug 6, 2021
Doctor making a consultation

Why ViewRay Crushed the Market on Thursday

Eric VolkmanJun 24, 2021
$1 bill folded into arrow trending up

Why ViewRay Stock Vaulted Higher Today

Keith SpeightsMay 7, 2021
Gloved hand holding a beaker full of money

Why ViewRay Stock Got Crushed Today

Eric VolkmanJan 22, 2021
GettyImages-601938756

Why ViewRay Stock Dropped Today

Prosper Junior BakinyJan 7, 2021
BUsinessman with hand over face talking on phone

Why ViewRay Stock Is Tanking Today

Brian FeroldiJan 13, 2020
LE campaign

Why Lands' End, Audentes Therapeutics, and ViewRay Jumped Today

Dan CaplingerDec 3, 2019
TWo business people shaking hands

Why ViewRay Stock Is Shooting Higher Today

Brian FeroldiDec 3, 2019
Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About ViewRay Systems

ViewRay, Inc. is a medical device company specializing in innovative radiation therapy systems that integrate magnetic resonance imaging (MRI) technology. The company focuses on improving cancer treatment through its advanced MRIdian A3i system, which offers real-time tissue tracking and automated beam control.

Products and Services
  • MRIdian A3i: MRI-guided radiation therapy system
  • Real-time 3D tissue tracking for precise treatment
  • Applications for various cancers including prostate and breast
Growth Outlook
  • Recent bankruptcy filing may lead to restructuring opportunities
  • Potential for increased adoption of MRI-guided therapies in oncology
  • Focus on expanding international market presence for products
Financial Highlights
  • Q1 2023 revenue of $22.5 million, down from $34.7 million in Q4 2022
  • Net income for Q1 2023 was -$28.9 million, reflecting ongoing operational challenges
  • Cash and cash equivalents at $81.3 million as of March 31, 2023
ViewRay, Inc. has faced significant challenges, including a recent bankruptcy filing that transitioned from Chapter 11 to Chapter 7. This situation may present opportunities for restructuring and revitalization. The company's flagship product, the MRIdian A3i, is positioned in a growing market for MRI-guided radiation therapy, which is gaining traction among healthcare providers. Despite recent financial difficulties, the company maintains a substantial cash reserve, which may support future operations and strategic initiatives. Investors may find interest in the potential for recovery and growth in the oncology treatment landscape.
AI Generated • Sep 30, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

295

CEO

Scott William Drake

Website

www.viewray.com

Headquarters

Oakwood Village, OH 44146, US

VRAYQ Financials

Key Financial Metrics (TTM)

Gross Margin

9.83%

Operating Margin

-104.81%

Net Income Margin

-105.01%

Return on Equity

-85.17%

Return on Capital

-63.52%

Return on Assets

-39.55%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$200.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

183.40M

Volume

6.50K

Avg. Volume

7.59K

Financials (TTM)

Gross Profit

$8.52M

Operating Income

-$109.28M

EBITDA

-$99.13M

Operating Cash Flow

-$112.92M

Capital Expenditure

-$3.86M

Free Cash Flow

-$116.78M

Cash & ST Invst.

$81.29M

Total Debt

$85.13M

ViewRay Systems Performance Analysis

ViewRay Systems annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 70,119,000N/A
20222022-12-31USD 102,206,00045.8%
ViewRay Systems sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22022-06-3017.3%
Q32022-09-3019.6%
Q42022-12-3131.0%
Q12023-03-31-35.0%
ViewRay Systems annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -0.67N/A
20222022-12-31USD -0.59-11.2%
ViewRay Systems sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22022-06-30-7.1%
Q32022-09-306.7%
Q42022-12-31-7.1%
Q12023-03-31-6.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2023YOY CHG

Revenue

$22.53M

+19.4%

Gross Profit

-$1.43M

-1621.3%

Gross Margin

-6.35%

N/A

Market Cap

$200.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$0.68

N/A

Employees

295

N/A

Net Income

-$28.86M

-12.0%

EBITDA

-$25.27M

-7.7%

Quarterly Fundamentals

Name
Q1 2023YOY CHG

Total Cash

$81.29M

-54.9%

Total Debt

$85.13M

+26.4%

Accounts Receivable

$47.53M

+69.7%

Inventory

$42.19M

+61.8%

Long Term Debt

$4.44M

-92.2%

Short Term Debt

$80.69M

+654.9%

Return on Assets

-39.55%

N/A

Return on Invested Capital

-61.28%

N/A

Free Cash Flow

-$54.78M

-63.0%

Operating Cash Flow

-$53.60M

-65.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HTGMQHTG Molecular Diagnostics, Inc.
$0.00+0.00%
NUWENuwellis, Inc.
$0.55-0.80%
WOKWORK Medical Technology Group Ltd. Class A
$1.09-18.66%
AEMDAethlon Medical, Inc.
$5.15-2.28%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$89.85-5.79%
NVDANvidia
$214.13-1.43%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$93.67-12.74%
CCCCCC Intelligent Solutions
$7.61-0.26%

Questions About VRAYQ

What is the current price of ViewRay Systems?

ViewRay Systems is trading at $0.00 per share.

What is the 52-week range for ViewRay Systems?

Over the past 52 weeks, ViewRay Systems has traded between $0.00 and $0.00.

How much debt does ViewRay Systems have?

As of the most recent reporting period, ViewRay Systems reported total debt of $86.40M.

How much cash does ViewRay Systems have on hand?

ViewRay Systems reported $135.96M in cash and cash equivalents in its most recent financial results.

What is ViewRay Systems’s dividend yield?

ViewRay Systems does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services